RxDoctor Payments Data

Donna Smailis, PA

Physician Assistant · Nashville, TNNPI 1710305313

Payments from drug & device makers

$1,290in general payments, 2019–2025

Across 61 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$316
  • AbbVie$258
  • Galderma Laboratories, L.p.$144
  • Axsome Therapeutics, Inc.$79
  • Corcept Therapeutics$65
  • Jazz Pharmaceuticals Inc.$60
  • plus $369 from 12 others

What the payments were for

  • Food & beverage$1,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,290 in reported general payments places this provider in the 70th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$10,832
Medicare patients
131
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$47,007
Breo ElliptaFluticasone/Vilanterol63$31,876
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$9,303
Incruse ElliptaUmeclidinium Bromide15$7,587
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$4,534
Armodafinil30$2,686
Albuterol Sulfate HfaAlbuterol Sulfate82$2,047
Ventolin HfaAlbuterol Sulfate13$1,750
Methylphenidate Hcl31$1,580
Modafinil26$921
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine21$807
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$690
Trazodone Hcl55$471
Clonazepam52$178
Prednisone39$119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$45$95,774148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →